Pamella Apriliana

Ms. Pamella Apriliana

Kobe University
orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 January 2025 in Fermentation
Verified
Journal Article
Open access
PDF file
Pamella AprilianaPamella Apriliana
Pamella Apriliana
Prihardi KaharPrihardi Kahar
Prihardi Kahar
NRNova Rachmadona
Nova Rachmadona
WRWitta Kartika Restu
Witta Kartika Restu
AKAkihiko Kondo
Akihiko Kondo
Chiaki OginoChiaki Ogino
Chiaki Ogino
The potential of Streptomyces jeddahensis for lipid production was investigated, focusing on its ability to utilize various carbon sources under different temperature conditions. Glucose and fatty acid derivatives (sodium hexanoate, sodium octanoate, and sodium decanoate) were tested at 30 °C, 37 °C, and 45 °C to optimize growth and lipid biosynthesis. The results revealed that 37 °C was the optimal temperature for lipid accumulation, with sodium octanoate leading to the highest lipid content. While growth declined at 45 °C, significant lipid production persisted, indicating an adaptive stress response. Gene expression analysis identified upregulation of key metabolic genes, including STSP_03080 (DGAT) and STSP_67970 (fabD), under thermal stress, highlighting enhanced fatty acid biosynthesis pathways. This study demonstrates the capacity of S. jeddahensis to efficiently convert medium-chain fatty acids into lipids, supporting its use as a sustainable and scalable platform for biodiesel production and other lipid-based industrial applications.

24 June 2024 in Engineering in Life Sciences
Verified
Journal Article
Open access
Pamella AprilianaPamella Apriliana
Pamella Apriliana
Prihardi KaharPrihardi Kahar
Prihardi Kahar
NKNorimasa Kashiwagi
Norimasa Kashiwagi
AKAkihiko Kondo
Akihiko Kondo
Chiaki OginoChiaki Ogino
Chiaki Ogino
The utilization of Streptomyces as a microbial chassis for developing innovative drugs and medicinal compounds showcases its capability to produce bioactive natural substances. Recent focus on the clustered regularly interspaced short palindromic repeat (CRISPR) technology highlights its potential in genome editing. However, applying CRISPR technology in certain microbial strains, particularly Streptomyces, encounters specific challenges. These challenges include achieving efficient gene expression and maintaining genetic stability, which are critical for successful genome editing. To overcome these obstacles, an innovative approach has been developed that combines several key elements: activation‐induced cytidine deaminase (AID), nuclease‐deficient cas9 variants (dCas9), and Petromyzon marinus cytidine deaminase 1 (PmCDA1). In this study, this novel strategy was employed to engineer a Streptomyces coelicolor strain. The target gene was actVA‐ORF4 (SCO5079), which is involved in actinorhodin production. The engineering process involved introducing a specific construct [pGM1190‐dcas9‐pmCDA‐UGI‐AAV‐actVA‐ORF4 (SCO5079)] to create a CrA10 mutant strain. The resulting CrA10 mutant strain did not produce actinorhodin. This outcome highlights the potential of this combined approach in the genetic manipulation of Streptomyces. The failure of the CrA10 mutant to produce actinorhodin conclusively demonstrates the success of gene editing at the targeted site, affirming the effectiveness of this method for precise genetic modifications in Streptomyces.

12 April 2019 in IOP Conference Series: Earth and Environmental Science
Verified
Conference Paper
Open access
NRN Rahmani
N Rahmani
Pamella AprilianaPamella Apriliana
Pamella Apriliana
AJA M Jannah
A M Jannah
SRS Ratnakomala
S Ratnakomala
PLP Lisdiyanti
P Lisdiyanti
YOYopi
Yopi

12 February 2026 in Fermentation
Verified
Journal Article
Open access
PDF file
TYTogo Yamada
Togo Yamada
Pamella AprilianaPamella Apriliana
Pamella Apriliana
Prihardi KaharPrihardi Kahar
Prihardi Kahar
TKTomoya Kobayashi
Tomoya Kobayashi
YMYutaro Mori
Yutaro Mori
Chiaki OginoChiaki Ogino
Chiaki Ogino
3-Amino-4-hydroxybenzoic acid (3,4-AHBA) is a non-proteinogenic aromatic compound that functions as a key biosynthetic precursor for diverse secondary metabolites with pharmaceutical and industrial value. Microbial production of 3,4-AHBA offers a sustainable alternative to petroleum-based chemical synthesis; however, metabolic complexity and trade-offs between growth and product formation constrain rational strain design. Here, genome-scale metabolic (GSM) modeling and flux balance analysis (FBA) were integrated with targeted genetic engineering to elucidate and enhance 3,4-AHBA production in Streptomyces thermoviolaceus. A genome-scale metabolic model was constructed and expanded by incorporating the nspH–nspI gene operon, which encodes the 3,4-AHBA biosynthetic pathway. In silico FBA predicted substantial rewiring of central carbon metabolism, with carbon flux redirected from glycolysis and the tricarboxylic acid cycle toward aspartate-derived intermediates and 3,4-AHBA synthesis, accompanied by reduced biomass-associated flux. Guided by these predictions, an engineered strain (St::NspHI) was developed and experimentally evaluated. Consistent with model predictions, the engineered strain exhibited lower growth rates and glucose uptake than the wild type, reflecting a metabolic burden. Nevertheless, 3,4-AHBA production was achieved exclusively in the engineered strain. Comparison of simulated and experimental fluxes revealed overestimation by FBA, likely due to secondary metabolism and incomplete genome annotation. Overall, GSM-guided design enables optimization of precursor production.

6 January 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
TYTogo Yamada
Togo Yamada
Pamella AprilianaPamella Apriliana
Pamella Apriliana
Prihardi KaharPrihardi Kahar
Prihardi Kahar
TKTomoya Kobayashi
Tomoya Kobayashi
YMYutaro Mori
Yutaro Mori
Chiaki OginoChiaki Ogino
Chiaki Ogino
3-Amino-4-hydroxybenzoic acid (3,4-AHBA) is a non-proteinogenic aromatic compound that functions as a key biosynthetic precursor for diverse secondary metabolites with pharmaceutical and industrial value. Microbial production of 3,4-AHBA offers a sustain-able alternative to petroleum-based chemical synthesis; however, metabolic complexity and trade-offs between growth and product formation constrain rational strain design. Here, genome-scale metabolic (GSM) modeling and flux balance analysis (FBA) were in-tegrated with targeted genetic engineering to elucidate and enhance 3,4-AHBA production in Streptomyces thermoviolaceus. A genome-scale metabolic model was constructed and ex-panded by incorporating the nspH–nspI gene operon, which encodes the 3,4-AHBA bio-synthetic pathway. In silico FBA predicted substantial rewiring of central carbon metabo-lism, with carbon flux redirected from glycolysis and the tricarboxylic acid cycle toward aspartate-derived intermediates and 3,4-AHBA synthesis, accompanied by reduced bio-mass-associated flux. Guided by these predictions, an engineered strain (St::NspHI) was developed and experimentally evaluated. Consistent with model predictions, the engi-neered strain exhibited lower growth rates and glucose uptake than the wild type, reflect-ing a metabolic burden. Nevertheless, 3,4-AHBA production was achieved exclusively in the engineered strain. Comparison of simulated and experimental fluxes revealed overes-timation by FBA, likely due to secondary metabolism and incomplete genome annotation. Overall, GSM-guided design enables optimization of precursor production.

26 December 2024 in Preprints.org
Verified
Preprint
Open access
PDF file
Pamella AprilianaPamella Apriliana
Pamella Apriliana
Prihardi KaharPrihardi Kahar
Prihardi Kahar
NRNova Rachmadona
Nova Rachmadona
WRWitta Kartika Restu
Witta Kartika Restu
AKAkihiko Kondo
Akihiko Kondo
Chiaki OginoChiaki Ogino
Chiaki Ogino
The potential of Streptomyces jeddahensis for lipid production was investigated, focusing on its ability to utilize various carbon sources under different temperature conditions. Glucose and fatty acid derivatives (sodium hexanoate, octanoate, and decanoate) were tested at 30°C, 37°C, and 45°C to optimize growth and lipid biosynthesis. The results revealed that 37°C was the optimal temperature for lipid accumulation, with sodium octanoate leading to the highest lipid content. While growth declined at 45°C, significant lipid production persisted, indicating an adaptive stress response. Gene expression analysis identified upregulation of key metabolic genes, including STSP_03080 (DGAT) and STSP_67970 (fabD), under thermal stress, highlighting enhanced fatty acid biosynthesis pathways. This study demonstrates the capacity of S. jeddahensis to efficiently convert medium-chain fatty acids into lipids, supporting its use as a sustainable and scalable platform for biodiesel production and other lipid-based industrial applications.